clinical imaging analysis | clinical imaging methods | clinical imaging method | clinical imaging techniques

International Society for Mental Imagery Techniques

develop new approaches to imaging | perform imaging technique development | develop new imaging techniques | devise and execute new approaches to radiography imaging

powerful imaging technologies

apply medical imaging technique | perform x-ray and ultrasound examinations | apply medical imaging techniques | use medical imaging techniques

Imaging guidance technique

(Return tabled) Question No. 1123 Ms. Kirsty Duncan: With respect to the government’s position on chronic cerebrospinal venous insufficiency (CCSVI): (a) does the government track clinical trials on CCSVI currently being undertaken by other countries and, if yes, what are all clinical trials, identified by phase, currently being undertaken worldwide, (i) which countries are undertaking Phase lll trials; (b) does the government question whether CCSVI exists and, if yes, (i) why does the government not question whether treating CCSVI actually improves quality of life for Canadians with multiple sclerosis (MS); (c) how many cases of " maj ...[+++]or complications associated with venous angioplasty" have occurred in Canada and, if it is not possible to give this number, why, (i) what are identified complications to CCSVI and, for each complication, how many cases versus the number of procedures undertaken have occurred; (d) what are all procedures that have been performed on veins in Canada, including, procedures for Budd-Chiari syndrome and May-Thurner syndrome; (e) what is the government's position on ballooning veins and why does it consider that ballooning veins even once could be unsafe on fragile veins, even though participants involved in the proposed clinical trial will experience two procedures-one real, one simulated-in a one-year period; (f) is the government consulting with Canadians with MS, if so, (i) provide a list of all CCSVI groups the Minister of Health has met with along with the dates of the meetings, (ii) provide a list of all MS groups the Minister of Health has met with along with the dates of the meetings, (iii) provide the number of Canadians with MS the Minister of Health has met and the dates of all meetings, and if the government is not consulting, (iv) why not; (g) how does inviting the investigators of the seven MS-funded CCSVI studies to participate in the consensus workshop on ultrasound imaging meet CIHR's conflict of interest g ...

- for health: personal non-obtrusive systems that enable citizens to manage their well-being such as wearable or implantable monitoring devices with communication capabilities and autonomous systems for supporting a healthy state; emerging techniques such as molecular imaging for improved prevention and individualised medicine; health knowledge discovery and application in clinical practice; modelling and simulation of organ functions; micro- and nano-robotic devices for minimally invasive surgical and therapeutic applications; r ...[+++]emote assistance and remote monitoring technologies for the chronically ill and for elderly people; computer aided detection and clinical decision support systems that lead to more reliable diagnosis and an improved workflow, eventually leading to disease specific expert systems taking an integral carecycle approach, and exploiting accumulated patient data, and model based disease knowledge through data mining, bioinformatics, and systems biology; enterprise IT systems leading to increased efficiency and reduced medical error in the hospital and in secondary care facilities;

- for health: personal non-obtrusive systems that enable citizens to manage their well-being such as wearable or implantable monitoring devices with communication capabilities and autonomous systems for supporting a healthy state; emerging techniques such as molecular imaging for improved prevention and individualised medicine; health knowledge discovery and application in clinical practice; modelling and simulation of organ functions; micro- and nano-robotic devices for minimally invasive surgical and therapeutic applications; r ...[+++]emote assistance and remote monitoring technologies for the chronically ill and for elderly people; computer aided detection and clinical decision support systems that lead to more reliable diagnosis and an improved workflow, eventually leading to disease specific expert systems taking an integral carecycle approach, and exploiting accumulated patient data, and model based disease knowledge through data mining, bioinformatics, and systems biology; enterprise IT systems leading to increased efficiency and reduced medical error in the hospital and in secondary care facilities;

- for health: personal non-obtrusive systems that enable citizens to manage their well-being such as wearable or implantable monitoring devices and autonomous systems for supporting a healthy state; emerging techniques such as molecular imaging for improved prevention and individualised medicine; health knowledge discovery and application in clinical practice; modelling and simulation of organ functions; micro- and nano-robotic devices for minimally invasive surgical and therapeutic applications;